Ascorbic acid could activate the FGF21/FGFR2/adiponectin pathway to alleviate hepatocyte stress as well as peroxisome proliferator-activated receptor α (PPARα) and improve the visceral obesity and NAFLD (65). The gene discussed is FGFR2; the disease is metabolic dysfunction-associated steatotic liver disease.